New iPhone 16 unveiled in Russia as retailers skirt Apple's export ban
Canada's 2023 emissions edged lower but progress slow, report says
Bank of England widely expected to hold interest rates despite big US Fed cut
Ukraine faces 6 GW power supply shortfall this winter, IEA says
Poland's third-largest city braces for peaking floods
Jimmy Carter receives Holbrooke award from Dayton Literary Peace Prize Foundation
The Thai zoo home to baby hippo and internet sensation Moo Deng is patenting the pygmy
A flying bat and a baserunning mistake cost Mariners chance to make up ground in playoff race
BRUSSELS (Reuters) - The Democratic Republic of Congo is set to receive its first batch of 100,000 mpox vaccines from the European Union on Thursday, with a second delivery expected in the coming days, the European Commission said.
WHY IT'S IMPORTANT
The delivery marks a significant step in curbing the mpox outbreak in Africa, particularly in Congo, which has been grappling with a severe shortage of vaccines.
CONTEXT
Congo, the epicentre of a recent mpox outbreak, has been awaiting vaccines. The World Health Organization declared a global public health emergency last month due to the outbreak, but containment efforts have been hampered by a lack of vaccines. The delivered vaccines were manufactured by Bavarian Nordic and donated by the EU as part of its commitment to tackle the health crisis.
BY THE NUMBERS
The EU has pledged to share 215,000 vaccine doses to affected African countries. An additional 351,500 doses will be donated by at least eight EU member states, bringing the total number of vaccine doses to at least 566,500.
WHAT’S NEXT
The EU will further support affected African countries by strengthening health systems, securing pharmaceutical supply chains, and developing local manufacturing. A 9.4-million-euro ($10.4 million) grant is also planned to expand access to diagnostics and sequencing by early autumn.
($1 = 0.9007 euros)
(Reporting by Charlotte Van Campenhout; Editing by Mark Potter)
